On Wednesday, June 8th, the FDA issued a warning letter to Whole Foods Markets Inc., citing the company’s Everett, Massachusetts manufacturing facility for several GMP violations. The violations involved FDA’s regulations for manufacturing, packing, or holding human food. In the warning letter, FDA stated that the violations cause the food products being manufactured at the facility to be “adulterated within the meaning of section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 United States Code (U.S.C.) § 342(a)(4)] in that they were prepared, packed, or held under insanitary conditions whereby they may have been contaminated with filth or rendered injurious to health.”
Following the inspection, Whole Foods received a Form FDA-483 on February 26, 2016, which outlined the serious violations that were observed by the Agency. These violations include:
On March 17, 2016, Whole Foods reacted to the observations and submitted a written response to the FDA. The warning letter states the company’s response indicated that Whole Foods takes the observations seriously and is committed to correcting the deficiencies. However, the FDA is still concerned that the company’s facility was operating under such conditions to begin with. Furthermore, the Agency notes that Whole Foods’ response “includes retraining of employees as a corrective action for most of the observed violations,” but the company “failed to mention adequate supervision over your specialized food processing operations and how retraining will ensure sustained compliance.”
In the warning letter, FDA states that it does not consider Whole Foods’ response to be acceptable because the company did not provide documentation for the Agency to review, demonstrating that all corrective actions have been effectively implemented. “This documentation may include photographs, invoices, work orders, voluntary destruction records of any affected products, certification of actions performed by contractors, and/or any other useful information that would assist us in evaluating your corrections.”
Whole Foods must respond to the warning letter within 15 days, listing the specific things that the company is doing to correct the violations. In addition, FDA states that the response “should include each step that has been taken or will be taken to correct the violations and prevent their recurrence.” If corrective action cannot be completed within 15 working days, Whole Foods must provide the reason for the delay and the time frame in which the corrections will be completed.
May 31, 2017
On Monday, May 22nd, the FDA issued a warning for drug manufacturers regarding the contamination risk posed by Burkholderia cepacia complex (BCC). According to FDA’s warning, “BCC and other...
January 21, 2016
On December 31, 2015, the FDA issued a Warning Letter to Zhejiang Hisun Pharmaceutical Co., Ltd., an Active Pharmaceutical Ingredient (API) manufacturer, citing the company for serious data...
February 15, 2017
In May 2016, the FDA inspected Resonance Laboratories Pvt. Ltd.’s Bangalore manufacturing facility. During this inspection, the FDA investigator observed a number of significant deviations from...